Drugs / Zishenqing
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04275193 | Oct 2019 → Mar 2022 | systemic lupus erythematosus | Shanghai University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zishenqing | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04275193 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional chinese medicine Zishenqing” NCT04275193 ↗ |
| Route | Oral | “Zishenqing 1Co by mouth,twice a day for 12 weeks” NCT04275193 ↗ |